The 4 analysts offering 1 year price forecasts for 6MD have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 6MD in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
According to analysts, 6MD price target is 140.98 CHF with a max estimate of 150.61 CHF and a min estimate of 130.07 CHF. Check if this forecast comes true in a year, meanwhile watch MEDACTA GROUP SA stock price chart and keep track of the current situation with 6MD news and stock market news.
We've gathered opinions of 5 analysts rating 6MD stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.